Скачать или смотреть Regents of California vs. Eli Lilly on Insulin Patents

This podcast discusses a 1997 decision by the United States Court of Appeals, Federal Circuit, concerning a patent infringement lawsuit between The Regents of the University of California (UC) and Eli Lilly and Company (Lilly). The case focuses on patents related to recombinant DNA technology used to produce human insulin, specifically U.S. Patent 4,652,525 ('525) and U.S. Patent 4,431,740 ('740). The court addressed multiple issues, affirming the district court's findings that asserted claims of the '525 patent were invalid for lacking an adequate written description of the claimed genetic material and that Lilly did not infringe the '740 patent. However, the appellate court reversed the lower court's finding that both patents were unenforceable due to inequitable conduct, determining that the alleged misrepresentations to the Patent and Trademark Office were not material. Ultimately, the judgment was affirmed-in-part and reversed-in-part, resulting in costs being awarded to Lilly.

Note: Please note that this AI-generated podcast is intended solely for general learning and educational purposes. While we strive to ensure accuracy, the AI may occasionally produce errors or incomplete information. We strongly encourage you to consult qualified professionals and conduct your own due diligence before making any legal, financial, or business decisions based on the content presented here.

Also Note: This podcast video is auto-dubbed in multiple languages, including Hindi, French, Japanese, Italian, German, Indonesian, Polish, Portugese, Spanish. To switch the audio language:

1. Click on the Settings (⚙️) icon in the video player.

2. Select "Audio Track" or "Audio".

3. Choose your preferred language from the list.

Enjoy the podcast in the language you're most comfortable with!